Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood. - Wikidata - awgldk - TriplyDB

Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.

Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.

http://www.wikidata.org/entity/Q37785538

about

Progress in Treatment of Viral Infections in Children with Acute Lymphoblastic Leukemia Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood.Controlling cytomegalovirus: helping the immune system take the lead Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo.Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus.Functionally Active HIV-Specific T Cells that Target Gag and Nef Can Be Expanded from Virus-Naïve Donors and Target a Range of Viral Epitopes: Implications for a Cure Strategy after Allogeneic Hematopoietic Stem Cell Transplantation General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation Umbilical cord blood immunology: relevance to stem cell transplantation.Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.Anticancer cellular immunotherapies derived from umbilical cord blood.

P2860

Q26740588-D2E0A0B3-3B69-4ABB-B264-BA5C5E883EA7 Q28730417-DC1AE513-6DE4-4642-840B-C4C08020B005 Q33633262-55A6E324-1C2B-414A-84E0-968ED886DC1E Q33820695-073322AF-43F3-4CEA-807D-BAB27E19ADD6 Q35582326-3832CC54-46DE-41F9-A9D4-2C444848E358 Q35776868-E998B707-9FB3-4687-9563-1D9D21714994 Q36305254-A3C7DD79-6B70-4BEF-992F-C26C9A02AD67 Q36578672-70D83159-C736-4BF4-8BDA-0319D086B6D9 Q36702752-2257A1D1-81FB-4281-82FB-ECFF4C347265 Q37963798-3795A7D2-562D-49B7-87CF-6553C33D9BE4 Q38797660-F4F776FD-C843-413B-B5C3-1D8CC868B73C Q47657491-DF0715EC-7952-4050-B6E9-010E5FB6C782

P2860

Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.

http://www.wikidata.org/entity/Q37785538

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improving clinical outcomes us ...... lls from umbilical cord blood.

@en

Improving clinical outcomes us ...... lls from umbilical cord blood.

@nl

type

label

Improving clinical outcomes us ...... lls from umbilical cord blood.

@en

Improving clinical outcomes us ...... lls from umbilical cord blood.

@nl

prefLabel

Improving clinical outcomes us ...... lls from umbilical cord blood.

@en

Improving clinical outcomes us ...... lls from umbilical cord blood.

@nl

P1433

Q37785538-2CE3FAAA-A625-43FB-A338-2F149BEE0A82

P1476

Q37785538-5CFBEF7C-289C-421C-88F0-57D2F5860377

P2093

Q37785538-311EAEA9-4668-47FA-962B-BEA44ECE13F5

Q37785538-9771BA2D-07B6-4627-BD7D-D62634F99372

Q37785538-9C70CA91-400A-4125-9761-5EEEC948D7E6

Q37785538-CD1FBD9E-580E-44D6-A567-072659C5FA4A

P2860

Q37785538-06FD09FF-052B-4986-BB1E-7F73BF0EB024

Q37785538-0712A619-2FF6-4CC0-8FFB-A1592F052AB2

Q37785538-235E67F6-47EB-42F9-B9CE-BBF4A5BC941D

Q37785538-237F46C4-1787-472D-A1FA-8C269485CFD1

Q37785538-25172796-0514-4491-AA48-1634B2FB483C

Q37785538-2CBAA8CB-D56B-47F6-9884-32AF00D088BC

Q37785538-2F1129E1-CAD8-405D-ABA0-0C5BDD15BE2A

Q37785538-305AA498-B8F7-4936-966D-4F28EF4C2FD8

Q37785538-31BD03CA-6A80-43E3-B1F7-5263870EAFDF

Q37785538-32D9779F-5937-4199-94EC-EB642812863E

P304

Q37785538-C098E6CB-796C-4CB2-83BE-AB1A99D11EB4

P31

Q37785538-179D946E-9EFB-4B32-B717-56CC0EB33FE8

P356

Q37785538-533921EA-B57C-4467-9869-3E7DB865E93B

P433

Q37785538-A512703B-14EA-405E-88E8-23BBCAFCD8BD

P478

Q37785538-70395D7E-E20C-428A-ACD2-6BDC79B4916B

P577

Q37785538-E5B53A0E-0392-4CB6-B94D-653CEA98A6E9

P5875

Q37785538-2D2B28F1-3005-4EE8-9C49-F5A6AE1B597F

P698

Q37785538-9EBF32AD-92BE-4E75-BC30-EF8F2474DCF2

P932

Q37785538-839A6B56-C730-4E7F-AFC9-4C43D2927B05

P356

14653249.2010.517518

P1433

P1476

Improving clinical outcomes us ...... lls from umbilical cord blood.

@en

P2093

Catherine M Bollard

http://www.w3.org/2001/XMLSchema#string

Conrad Russell Cruz

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

Patrick J Hanley

http://www.w3.org/2001/XMLSchema#string

P2860

High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.

Targeting tumours with genetically enhanced T lymphocytes.

P304

713-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14653249.2010.517518

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46157389

http://www.w3.org/2001/XMLSchema#string

P698

20818913

http://www.w3.org/2001/XMLSchema#string

P932

3178185

http://www.w3.org/2001/XMLSchema#string